KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolent Health (EVH) Leases (2019 - 2026)

Evolent Health has reported Leases over the past 7 years, most recently at $4.4 million for Q4 2025.

  • For Q4 2025, Leases fell 28.71% year-over-year to $4.4 million; the TTM value through Dec 2025 reached $4.4 million, down 28.71%, while the annual FY2025 figure was $4.4 million, 28.71% down from the prior year.
  • Leases for Q4 2025 was $4.4 million at Evolent Health, down from $4.8 million in the prior quarter.
  • Over five years, Leases peaked at $53.7 million in Q1 2021 and troughed at $4.4 million in Q4 2025.
  • A 5-year average of $28.1 million and a median of $22.4 million in 2023 define the central range for Leases.
  • Biggest five-year swings in Leases: grew 1.15% in 2022 and later tumbled 75.7% in 2024.
  • Year by year, Leases stood at $50.2 million in 2021, then fell by 2.34% to $49.0 million in 2022, then tumbled by 75.56% to $12.0 million in 2023, then tumbled by 48.81% to $6.1 million in 2024, then fell by 28.71% to $4.4 million in 2025.
  • Business Quant data shows Leases for EVH at $4.4 million in Q4 2025, $4.8 million in Q3 2025, and $5.3 million in Q2 2025.